Search
Kymera Therapeutics Inc
KYMRAdd to Watchlist
116.330USD
+3.180+2.81%
Close 09-16 16:00（ET）
9.64BMarket Cap
LossP/E TTM
KYMR Financials
See Kymera Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
9.64B
Dividend TTM
0.00
P/E TTM
-32.56
EPS TTM
-3.58
Revenue
39.21M
Net Profit
-223.86M
ROE
-27.09%
ROA
-24.35%
Kymera Therapeutics Inc Earnings Date
Latest Release
Aug 5, 2026
EPS / Forecast
-0.62/-0.71
Revenue / Forecast
65.00M/31.16M
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What is the total revenue of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its total revenue reached 39.21M, with a year-on-year change of 47.07M.
What are the current assets of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its current assets were 871.21M, with a year-on-year change of 70.74.
What are the total assets of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its total assets of Kymera Therapeutics Inc were 1.74B, with a year-on-year change of 78.20.
What are the total liabilities of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its total liabilities of Kymera Therapeutics Inc were 163.15M, with a year-on-year change of 14.56.
What is the total equity of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its total equity of Kymera Therapeutics Inc was 1.58B, with a year-on-year change of 89.04.
What is the net operating income of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its net operating income of Kymera Therapeutics Inc was -345.54M, with a year-on-year change of -34.60.
What is the net investment of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its net investment of Kymera Therapeutics Inc was -521.06M, with a year-on-year change of -28.95.
What is the net financing of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its net financing of Kymera Therapeutics Inc was 990.71M, with a year-on-year change of 62.72.
What is the Earnings Per Share (EPS) of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.69, with a year-on-year change of -23.53.
What is the net income of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its net income was -311.35M, with a year-on-year change of -39.08.
What is the net margin of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its net profit margin was -794.04, with a year-on-year change of -66.97.
What is the debt-to-asset ratio of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.19, with a year-on-year change of -50.88.
What is the Return on Equity (ROE) of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -25.78, with a year-on-year change of 29.14.
What is the Return on Assets (ROA) of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -22.89, with a year-on-year change of 20.57.
What is the operating profit of Kymera Therapeutics Inc?
According to Kymera Therapeutics Inc's FY2025 earnings report, its operating profit was -345.54M, with a year-on-year change of -34.60.